![]() |
|
|||
|
May 25 (Bloomberg) -- GTx Inc. said its experimental drug for prostate cancer failed to show a significant benefit in a final-stage clinical trial, sending shares down 35 percent in extended trading.
|
| Thread Tools | |
| Display Modes | |
|
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| AstraZeneca drug fails in prostate cancer trial | cancerfr | Latest Cancer News | 0 | 09-28-2010 06:01 PM |
| AstraZeneca drug fails in prostate cancer trial | cancerfr | Latest Cancer News | 0 | 09-27-2010 08:47 PM |
| AstraZeneca Prostate Cancer Drug Fails | cancerfr | Latest Cancer News | 0 | 09-27-2010 08:47 PM |
| Chemotherapy After Gastric Cancer Surgery Appears To Provide Survival Benefit | cancerfr | Stomach (Gastric) Cancer | 0 | 05-05-2010 08:16 PM |
| Chemotherapy after gastric cancer surgery appears to provide survival benefit | cancerfr | Stomach (Gastric) Cancer | 0 | 05-05-2010 01:24 AM |